January 27, 2014
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee, an advisory organ to the health minister, recommended approval of Bristol-Myers’s dapagliflozin for the treatment of type 2 diabetes on January 24. Dapagliflozin will be the second sodium-glucose co-transporter-2 (SGLT-2)...read more